EQL Pharma AB logo

EQL Pharma AB

kr 30.00 (-2.6%) Aug 17
P/E:
27.42
P/B:
7.05
Market Cap:
kr 871.91M ($ 83.82M)
Enterprise V:
kr 906.81M ($ 87.17M)
Volume:
21.75K
Avg Vol (2M):
3.15K
Also Trade In:
Volume:
21.75K
Market Cap kr:
871.91M
Market Cap $:
83.82M
PE Ratio:
27.42
Avg Vol (2-Month):
3.15K
Enterprise Value kr:
906.81M
Enterprise Value $:
87.17M
PB Ratio:
7.05
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Description
EQL Pharma AB is a pharmaceutical company engaged in developing and selling medicines to pharmacies and hospitals. The products offered by the company include generics and parallel imports. It operates and markets products to Nordic countries of Sweden, Denmark, Finland and Norway.
Name Current Vs Industry Vs History
Cash-To-Debt 0.54
Equity-to-Asset 0.52
Debt-to-Equity 0.62
Debt-to-EBITDA 1.96
Interest Coverage 13.42
Piotroski F-Score 8/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 7.52
Distress
Grey
Safe
Beneish M-Score -1.64
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 36.28
9-Day RSI 44.62
14-Day RSI 48.4
6-1 Month Momentum % -22.13
12-1 Month Momentum % -23.63

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.25
Quick Ratio 0.83
Cash Ratio 0.42
Days Inventory 76.33
Days Sales Outstanding 40.72
Days Payable 31.77

Dividend & Buy Back

Name Current Vs Industry Vs History

Financials (Next Earnings Date:2022-11-11)

XSAT:EQL's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil kr) 410.386
EPS (TTM) (kr) 1.094
Beta 0.78
Volatility % 33.22
14-Day RSI 48.4
14-Day ATR (kr) 1.979782
20-Day SMA (kr) 30.395
12-1 Month Momentum % -23.63
52-Week Range (kr) 24.9 - 48.7
Shares Outstanding (Mil) 29.06

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 8
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

EQL Pharma AB Filings

Document Form Filing Date
No Filing Data